Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Osteoporosis Screening Is Underutilized Despite Recommendations

Mary Beth Nierengarten  |  Issue: August 2017  |  August 15, 2017

For years, guidelines from various organizations have recommended osteoporosis screening in women and men starting at a specific age or based on specific risk factors. Among these guidelines are those developed by the U.S. Preventive Services Task Force (USPSTF) that recommend universal osteoporosis screening for women 65 years of age and older and for targeted screening in all women younger than 65 years with risk factors for osteoporosis.1

Despite efforts to improve utilization of osteoporosis screening, data from two recent studies confirm what is now well documented: Utilization remains woefully low, even in women following a first hip fracture.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“Our findings underscore the persistent failure to align real-world implementation of osteoporosis screening among older women with evidence-based guidelines,” says Catherine Gillespie, PhD, MPH, AARP Public Policy Institute, Washington, D.C.

Dr. Gillespie

Dr. Gillespie

Dr. Gillespie, along with coinvestigator Pamela E. Morin, MBA, conducted the studies to look at utilization of osteoporosis screening in two patient cohorts. Both studies looked at contemporary trends and patterns of osteoporosis screening in privately insured women in the U.S. aged 50 years and older.2,3 One study looked at utilization trends in 1,638,454 women with no prior history of osteoporosis diagnosis, drug use for osteoporosis or hip fracture.2 A second study examined trends in utilization of osteoporosis-related health services, including screening, within six to 12 months following first-time hip fracture in a cohort of 8,349 women.3

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Both studies found deficiencies in how osteoporosis screening is being implemented, with each study providing important information on specific patterns of underutilization.

Primary Prevention

With the aim of describing patterns of osteo­porosis screening in U.S. women aged 50 and older with no prior history of osteoporosis, Dr. Gillespie and Ms. Morin retrospectively looked at screening rates between 2008 and 2014 among 1,638,454 U.S. women grouped into three age groups: 50–64 years, 65–79 years and 80+ years.2

The study found that overall screening rates remain low in all three age groups, with 21.1% of women screening in the 50–64-year-old age group, 26.5% in the 65–79-year-old age group, and 12.8% in women aged 80 and older. However, the study found that year-over-year changes in screening utilization in two age groups were in line with national recommendations, showing that screening rates in these age groups are moving in the right direction, says Dr. Gillespie. Although still low, screening rates increased by 38% for women aged 80 and older. For women aged 50–64 years of age, screening rates decreased by 31%, which Dr. Gillespie says is in line with the Choosing Wisely campaign that recommended against universal screening for younger women given its lack of cost effectiveness.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:bone density testbone diseasebone massbone mineral density (BMD)Fractureship fractureOsteoporosispreventionResearchrheumatologistscreeningWomen

Related Articles

    Unexpected Benefits of Bisphosphonates after Hip Fracture

    February 3, 2012

    Recent trials show this bisphosphonates can reduce subsequent hip fractures and mortality, while remaining cost effective.

    Build Up Bone

    June 1, 2007

    Current management of osteoporosis

    Osteoporosis Experts Discuss Bisphosphonate Holidays

    November 24, 2020

    ACR CONVERGENCE 2020—Bisphosphonates are an important treatment for millions of older Americans with osteoporosis because the drugs inhibit osteoclastic bone resorption to reduce the risk of painful, debilitating fractures.1 More than 20 years ago, data emerged that bisphosphonates have a long terminal half-life.2 So after years of therapy, could some patients take a drug holiday?…

    Prevent Osteoporotic Fractures with a Fracture Liaison Service

    May 18, 2019

    Imagine leaving the hospital after suffering a heart attack without being treated for hypertension or being started on a beta blocker. What would we think of the hospital where patients are never educated about the relationship between treating hypertension and reducing myocardial infarction and stroke risk? Unfortunately, this happens every day with osteoporosis and fractures…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences